Ricerca avanzata

Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2015 Ottobre;106(5 Suppl 1) > Minerva Medica 2015 Ottobre;106(5 Suppl 1):1-8

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236

 

Minerva Medica 2015 Ottobre;106(5 Suppl 1):1-8

PNEUMOLAB PROCEEDINGS 

Anxiety and depression in cystic fibrosis

Baiardini I. 1, Steinhilber G. 2, Di Marco F. 3, Braido F. 4, Solidoro P. 5

1 Allergy and Respiratory Diseases Clinic, DIMI, University of Genoa, IRCCS AOU San Martino‑IST, Genova, Italy;
2 Division of Respiratory Physiopathology, Division of Pulmonology, Spedali Civili di Brescia Hospital, Brescia, Italy;
3 Clinica di Malattie Respiratorie UOC Pneumologia, Ospedale San Paolo, Milan, Italy;
4 Allergy and Respiratory Diseases, Department of Internal Medicine (DIMI), Azienda Ospedaliera Universitaria, IRCCS San Martino di Genova, Genova, Italy;
5 S.C. Pneumologia, Dipartimento Cardiovascolare e Toracico, A.O. Città della Salute e della Scienza di Torino, Turin, Italy

Cystic fibrosis (CF) is the most common genetic disorders in the Caucasian population, with estimated between 70,000 and 100,000 patients worldwide. Even if improved diagnostics and clinical management have led to an increased life expectancy, CF still remains a disease that significantly impacts patients’ life in terms of symptoms, daily functioning, psychological morbidity and health related quality of life. Available data suggest that symptoms of anxiety and depression, such as in other chronic conditions, are common features in CF patients and in their caregivers, with a significant impact on disease outcomes. In this review we analyze and discuss the findings of The International Depression and Anxiety Epidemiological Study (TIDES), recently published on Thorax. This study was aimed to determine the prevalence of symptoms of depression and anxiety in a large population of adolescents and adults with CF and in parents of children with CF, across eight European countries and the USA. The TIDES provides useful insights about the psychological/psychiatric comorbidities in CF and its conclusions are absolutely shareable. Nevertheless some doubts remain on the methods and the tools. Further investigation and understanding of anxiety and depression in CF (in terms of prevalence, association with clinical, psychological and socio-cultural factors) is necessary and evidence is crescent that a global and multidisciplinary approach is wanted.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina